Healthcare stocks

247 listed companies in the Healthcare sector.

CompanyPriceChangeMarket capP/EDividend
Eli Lilly andLLY$1,443.50+1.14%$1.29T46.90.5%
Johnson & JohnsonJNJ$285.75+0.79%$687.89B43.41.8%
AbbVieABBV$295.03+0.20%$521.5B50.62.3%
Roche HoldingROPCHF 407.60+0.72%CHF 322.45B26.42.4%
UnitedHealth GroupUNH$407.46+0.58%$365.09B23.32.2%
MerckMRK · NYSE$147.76+0.55%$364.26B147.82.3%
NovartisNOVN · SIXCHF 135.64+1.18%CHF 253.19B32.12.7%
AstraZenecaAZN · LSE14,030.00 GBp+0.34%£216.85B26.51.7%
Thermo Fisher ScientificTMO$700.22+0.11%$259.44B36.90.3%
AmgenAMGN$465.67−0.30%$251.89B27.02.1%
Gilead SciencesGILD$168.08+0.08%$208.48B—1.9%
Abbott LaboratoriesABT$108.52+1.18%$187.95B40.52.3%
Novo NordiskNOVO.B · Nasdaq Copenhagenkr 287.70+3.32%kr 1.23T10.94.1%
PfizerPFE$28.89+0.21%$164.67B41.36.0%
DanaherDHR$233.02+0.37%$163.94B38.60.7%
Intuitive SurgicalISRG$443.59+0.84%$153.77B53.6—
Vertex PharmaceuticalsVRTX$538.60−0.74%$136.56B34.7—
MedtronicMDT$102.86+1.85%$131.57B25.32.8%
Bristol-Myers SquibbBMY$63.43+1.78%$129.66B14.14.0%
McKessonMCK$1,102.81+2.39%$127.33B28.40.3%
StrykerSYK$309.64−0.88%$117.88B33.01.1%
SanofiSAN · Euronext Paris€87.80+0.23%€105.17B25.34.7%
CVS HealthCVS$89.35−0.49%$114.32B10.43.0%
HCA HealthcareHCA$499.05−0.32%$104.25B16.60.6%
GSKGSK · LSE1,929.00 GBp+0.92%£76.63B17.93.6%
Regeneron PharmaceuticalsREGN$955.47+0.45%$98.84B21.10.4%
EssilorLuxotticaEL€184.80+1.34%€83.58B34.12.2%
ModernaMRNA$223.37−3.45%$90.38B——
CencoraCOR$359.03+2.76%$68.51B20.00.7%
WuXi AppTec603259¥144.41−1.29%¥444.01B16.30.4%
CSLCSL$202.52−0.20%$96.75B—2.0%
Boston ScientificBSX$44.34+0.32%$64.27B18.7—
UCBUCB€295.70−0.27%€56.53B26.20.5%
Edwards LifesciencesEW$107.15+1.28%$61.61B61.6—
BayerBAYN€57.04+0.92%€55.53B—0.2%
argenxARGX · NASDAQ$960.04−2.17%$60.37B33.3—

About the Healthcare sector

The health care sector includes pharmaceutical and biotechnology companies, makers of medical devices and diagnostics, and providers of health services and insurance.

Drug makers depend on research pipelines, clinical trial results and patent expiries; device makers on innovation and hospital spending; service providers on regulation and reimbursement rules. Demand for health care is relatively stable through economic cycles, which is why the sector is often considered defensive.